Answer
Effects on driving and using machines are considered not relevant for Synagis (palivizumab).
Sources for this answer
- Synagis 50 mg/0.5 ml solution for injectionAstraZeneca UK Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 5Document updated
Sources checked